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ABSTRACT
Objective: This study was aimed to identify the pattern of presentation, influencing factors, and sort of the fungal species, distribution of sex of 
patients with otomycosis.
Methods: Eighty-six patients attended to Ad-Diwaniyah teaching hospital, Iraq were screened for identification of fungi causing otomycosis from 
October 2014 to November 2015. 50 patients were females while 36 patients were males. 12 patients of the total number were with bilateral 
involvement. Diabetes mellitus, leukemia, chemotherapy, and chemoradiation were the associated systemic diseases which were recorded in patients 
with otomycosis and diabetes mellitus was detected in 53.84% of patients with systemic diseases.
Results: The predominant complaints were pruritus and found in 76 patients (88.73%), discomfort and pain found in 62 patients (72.09%), aural 
fullness in 48 patients (55.81%), tinnitus in 34 patients (39.53%), hearing impairment in 50 cases (58.31%), ear discharge in 22 patients (25.58%), 
and most of the symptoms seen in 36 patients (68.14%). The results showed a total of eight fungal species belong to six different genera, namely, 
Aspergillus, Candida, Penicillium, Rhizopus, Alternaria, and Cephalosporium were isolated during this study. Among identified fungi, Aspergillus niger 
was found to be the most prevalent fungal species with 35.71% followed by Candida albicans (27.55%), Aspergillus flavus (10.20%), Aspergillus 
fumigatus (8.16), Penicillium digitatum (6.12%) and Cephalosporium species (4.08%), and Rhizopus species (5.1%), while Alternaria alternata had the 
lowest percentage (6.54%).
Conclusion: Otomycosis/mycotic otitis externa is still a common problem and there is a rise in the occurrence of otomycosis in latest years, especially 
in tropical and subtropical humid climates.
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INTRODUCTION
Otitis externa is a generic name for inflammation in living external 
auditory canal (EAC) that may affect part of the canal but can involve 
the segment of meatus which extends to tympanic membrane without 
spreading to the cleft of the middle ear. The problem usually is 
infectious which may be bacterial or fungal in origin [1-3] but can be 
associated with different types of non-infectious constitutional or local 
skin diseases [4]. Warm, dark, and moist setting of the EAC is the perfect 
medium for rapid growth of bacteria and fungi [5].
The term otomycosis employed to declare a superficial, diffuse fungal 
infection of the external auditory meatus. It is generally considered to be 
opportunistic occurring after treatment of bacterial infection and develops 
unilaterally in healthy persons and in many times a pride posing problem 
is present [6-8]. It has been found that otitis externa (OE) constitutes 
about 5–20% of ear consultations to otorhinolaryngologists; the majority 
of these cases are caused by bacteria and in 9–25% fungal agents are the 
cause and the microorganisms which attribute for these clinical conditions 
are present as saprobes in nature [9-11]. Otomycosis can be presented 
with non-specific manifestations such as itching, discomfort and otalgia, 
aural fullness, tinnitus decrease in hearing and otorrhea [12-15]. There 
are many factors which may take important roles in fungal infection of the 
ear like humidity moisture Warmth,  darkness and water access into the 
external auditory canal during bathing decreased immune function, pre-
existing ear diseases, cleaning of ear wax, and comorbid conditions such 
as diabetes and dermatological diseases [16-19].
There are many studies which show that there had been a rise in the 
occurrence of otomycosis in latest years which were linked to the 
extensive use of antibiotic ear drops, widespread use of corticosteroids, 
and chemotherapeutic agents [12,20,21]. Secondary overgrowth of 
fungi is well-known and recognized complication of the use of broad-
spectrum antibiotics such as fluoroquinolones and cephalosporins 
[12,20,22-24]. Prevalence is also influenced by the geographical area, 
as otomycosis is most commonly present in tropical and subtropical 
humid climates [12,13,25-27]. The most common species encountered 
in cases of otomycosis are Aspergillus and Candida [28-30].
METHODS
This study was conducted in Ad-Diwaniyah teaching hospital, 
Diwaniyah city, Iraq, from October 2014 to November 2015. All patients 
presenting to the outpatient department with a clinical diagnosis of 
otomycosis agreed with the inclusion criteria were involved in the 
study. The inclusion standards were patients of either sex, aged beyond 
10 years, and consuming features of fungal otitis externa. The patients 
with a history of chronic otitis media or mastoid cavity were excluded 
from the study. To determine the genera and species of fungi causing 
otomycosis, the samples from the ear were put with sterile swab sticks 
which were appropriately categorized demonstrating the source, name 
and age of patient, data, and time of collection. All patients were not 
receiving any local or systemic antibiotics or antifungals at least for 
the last 3 days. The samples were directly taken to the microbiology 
laboratory of Ad-Diwaniyah teaching hospital.
Diagnosis
The swab sticks were streaked directly on the Sabouraud Dextrose Agar 
plates and incubated at 25 ± 2 C. The growth was visible within 5–7 days. 
Each fungal growth was identified based on their morphological and 
cultural characteristics and microscopic examination was done using 
lactophenol staining technique [31]. The finding of otomycosis was 
depending on patients giving a green/gray or black discharge besides 
microscopic examination viewing fungal spores and hyphae. Informed 
consents were obtained from all patients.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Statistical analysis
Collected data were analyzed using SPSS (statistical package for the social 
sciences), version 20. Descriptive analysis of means and standard deviation 
were calculated on all demographic variables, multiple comparisons of 
paired series of data within groups were done using ANOVA test. Unpaired 
t-test was then used to evaluate the difference between the two groups. 
p<0.05 was considered the minimum for statistical significance.
RESULTS
Of total 86 patients with clinical diagnosis of otomycosis who were 
submitted for the study, 50 patients were females while 36 patients 
were males. 12 patients of the total number were with bilateral 
involvement (Fig. 1).
In this study, the predominant complaints were pruritus and found in 
76 patients (88.73%), discomfort and pain found in 62 patients (72.09%), 
aural fullness in 48 patients (55.81%), tinnitus in 34 patients (39.53%), 
hearing impairment in 50 cases (58.31%), ear discharge in 22 patients 
(25.58), and most of the symptoms seen in 36 patients (41.86%) (Fig. 2).
About 30 cases (34.88%) of the tolerant provided a past of handling/
trauma to the EAC with either stick, metallic picker, pin, or other 
instruments, 21 patients (24.41%) provided a past of using either 
antibiotic ear drops, antibiotic-steroid ear drops, or the use of garlic 
into the ear. Furthermore, 13 patients (15.11%) had related systemic 
disorders, and 22 patients (25.58%) had no predisposing factors (Fig. 3).
Diabetes mellitus was detected in seven patients (53.84%) of total cases 
associated with systemic diseases which were recorded in our patients 
with otomycosis; one case (7.69%) was detected in each of leukemia, 
chemotherapy, kidney transplant and two cases (15.38%) in patients 
receiving chemoradiation (Fig. 4 and Table 1).
The results summarized in Table 2 showed a total of eight fungal species 
belong to six different genera, namely, Aspergillus, Candida, Penicillium, 
Rhizopus, Alternaria, and Cephalosporium were isolated during this 
study. Among identified fungi, Aspergillus niger was found to be the 
most prevalent fungal species with (35.71%) followed by Candida 
albicans (27.55%), Aspergillus flavus (10.20%), Aspergillus fumigatus 
(8.16), Penicillium digitatum (6.12%) and Cephalosporium species 
(4.08%), and Rhizopus species (5.10%), while Alternaria alternata had 
the lowest percentage (3.06%).
DISCUSSION
Although there is a controversy with respect to whether fungi are the 
true infective agents versus mere colonization species as a results of 
compromised local host immunity secondary to bacterial infection, most 
clinical and laboratory evidence to date supports otomycosis as a true 
pathogenic entity, with C. albicans and A. niger as the most common 
Table 1: Age range of patients
Age range in years Number of patients (%)
10–20 4 (4.65)
21–30 8 (9.30)
31–40 21 (24.41)
41–50 18 (20.93)
51–60 15 (17.44)
61–70 12 (13.95)
Above 71 8 (9.30)
Total 86 (100)
Table 2: Percentage and frequency of fungal infections causing 
otomycosis
Fungal isolates Number of isolates Percentage of 
occurrence (%)
A. niger 35 35.71
C. albicans 27 27.55
A. flavus 10 10.20
A. fumigatus 8 8.16
P. digitatum 6 6.12
Cephalosporium sp 4 4.08
Rhizopus sp. 5 5.10
A. alternate 3 3.06
Total 98 %855
A. niger: Aspergillus niger, C. albicans: Candida albicans, A. flavus: Aspergillus 
flavus, A. fumigatus: Aspergillus fumigatus, P. digitatum: Penicillium digitatum, A. 
alternate: Alternaria alternate
Fig. 1: Sex distribution of otomycosis
Figure (2) distribution of features
Figure (3) distribution of predisposing factors
Figure (4) distribution of associated systemic diseases
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fungal species isolated [18,32,33]. Classically, fungal infection is the 
result of prolonged treatment of bacterial otitis externa that alters the 
flora of the ear canal, mixed bacterial, and fungal infections are thus 
common. However, the fungus is occasionally the primary pathogen in 
otitis externa, especially in the presence of excessive moisture or heat [4].
Study by Jackman et al. [22] assessed the contribution of topical 
antibiotic ear drops to the development of ear fungal infections, their 
research had revealed that ofloxacin may contribute to the development 
of otomycosis in two ways; first, this antibiotic is bactericidal to most 
bacteria in the external auditory meatus, and fungal proliferation may 
occur because of the lack of competing for bacterial growth, and second, 
in contrast to other topical antibiotic ear drops which typically have a pH 
of 3–4, ofloxacin ear drops have a pH of 7, this is a more neutral solution 
and will not acidify the pH of the external auditory canal skin making 
it a more optimal environment for fungal growth and proliferation 
(Aspergillus grows optimally at a pH of 6). These two properties of 
topical ofloxacin ear drops may explain its association with otomycosis.
The diagnosis of fungal infections of the ear can be challenging given its 
non-specific symptoms and may be misdiagnosed for other chronic otitis 
externa conditions. Recurrence after treatment is not uncommon, and 
eradication of disease can be particularly difficult in some cases [20,34].
Otolaryngologists should remain alert for detection of otomycosis 
and should consider obtaining culture when this disease is suspected. 
The findings in this study are in general agreement with the findings 
observed by earlier workers like Rutt et al. [35] and Ozcan et al. [36].
CONCLUSION
Otomycosis/mycotic otitis externa is still a common problem and there 
is a rise in the incidence of otomycosis in latest years, especially in 
tropical and subtropical humid climates. It presents with non-specific 
symptoms and so may be misdiagnosed for other chronic otitis externa 
conditions. The most common species encountered in this study are 
Aspergillus and Candida.
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